• Je něco špatně v tomto záznamu ?

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases

A. Jafarzadeh, P. Chauhan, M. Nemati, S. Jafarzadeh, A. Yoshimura

. 2023 ; 53 (11) : 1147-1161. [pub] 20230828

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000874

Suppressor of cytokine signalling (SOCS) proteins bind to certain cytokine receptors, Janus kinases and signalling molecules to regulate signalling pathways, thus controlling immune and inflammatory responses. Dysregulated expression of various types of SOCS molecules was indicated in multiple types of allergic diseases. SOCS1, SOCS2, SOCS3, SOCS5, and cytokine-inducible SH2 domain protein (CISH) can differentially exert anti-allergic impacts through different mechanisms, such as suppressing Th2 cell development and activation, reducing eosinophilia, decreasing IgE production, repressing production of pro-allergic chemokines, promoting Treg cell differentiation and activation, suppressing Th17 cell differentiation and activation, increasing anti-allergic Th1 responses, inhibiting M2 macrophage polarization, modulating survival and development of mast cells, reducing pro-allergic activity of keratinocytes, and suppressing pulmonary fibrosis. Although some anti-allergic effects were attributed to SOCS3, it can perform pro-allergic impacts through several pathways, such as promoting Th2 cell development and activation, supporting eosinophilia, boosting pro-allergic activity of eosinophils, increasing IgE production, enhancing the expression of the pro-allergic chemokine receptor, reducing Treg cell differentiation, increasing pro-allergic Th9 responses, as well as supporting mucus secretion and collagen deposition. In this review, we discuss the contrasting roles of SOCS proteins in contexts of allergic disorders to provide new insights regarding the pathophysiology of these diseases and possibly explore SOCS proteins as potential therapeutic targets for alleviating allergies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000874
003      
CZ-PrNML
005      
20240213093432.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cea.14385 $2 doi
035    __
$a (PubMed)37641429
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Jafarzadeh, Abdollah $u Department of Immunology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran $u Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran $1 https://orcid.org/0000000281800602
245    10
$a Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases / $c A. Jafarzadeh, P. Chauhan, M. Nemati, S. Jafarzadeh, A. Yoshimura
520    9_
$a Suppressor of cytokine signalling (SOCS) proteins bind to certain cytokine receptors, Janus kinases and signalling molecules to regulate signalling pathways, thus controlling immune and inflammatory responses. Dysregulated expression of various types of SOCS molecules was indicated in multiple types of allergic diseases. SOCS1, SOCS2, SOCS3, SOCS5, and cytokine-inducible SH2 domain protein (CISH) can differentially exert anti-allergic impacts through different mechanisms, such as suppressing Th2 cell development and activation, reducing eosinophilia, decreasing IgE production, repressing production of pro-allergic chemokines, promoting Treg cell differentiation and activation, suppressing Th17 cell differentiation and activation, increasing anti-allergic Th1 responses, inhibiting M2 macrophage polarization, modulating survival and development of mast cells, reducing pro-allergic activity of keratinocytes, and suppressing pulmonary fibrosis. Although some anti-allergic effects were attributed to SOCS3, it can perform pro-allergic impacts through several pathways, such as promoting Th2 cell development and activation, supporting eosinophilia, boosting pro-allergic activity of eosinophils, increasing IgE production, enhancing the expression of the pro-allergic chemokine receptor, reducing Treg cell differentiation, increasing pro-allergic Th9 responses, as well as supporting mucus secretion and collagen deposition. In this review, we discuss the contrasting roles of SOCS proteins in contexts of allergic disorders to provide new insights regarding the pathophysiology of these diseases and possibly explore SOCS proteins as potential therapeutic targets for alleviating allergies.
650    _2
$a lidé $7 D006801
650    12
$a alergie $x metabolismus $7 D006967
650    _2
$a proteiny SOCS $x genetika $x metabolismus $7 D050826
650    _2
$a cytokiny $x metabolismus $7 D016207
650    12
$a eozinofilie $7 D004802
650    12
$a antialergika $7 D018926
650    _2
$a imunoglobulin E $x metabolismus $7 D007073
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Chauhan, Prashant $u Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic $u Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic
700    1_
$a Nemati, Maryam $u Department of Hematology and Laboratory Sciences, School of Para-Medicine, Kerman University of Medical Sciences, Kerman, Iran $u Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
700    1_
$a Jafarzadeh, Sara $u Student Research Committee, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
700    1_
$a Yoshimura, Akihiko $u Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan
773    0_
$w MED00009468 $t Clinical and experimental allergy $x 1365-2222 $g Roč. 53, č. 11 (2023), s. 1147-1161
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37641429 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093429 $b ABA008
999    __
$a ok $b bmc $g 2049469 $s 1210568
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 53 $c 11 $d 1147-1161 $e 20230828 $i 1365-2222 $m Clinical and experimental allergy $n Clin Exp Allergy $x MED00009468
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace